AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

NASDAQ:NHNantHealth Stock Price, Forecast & News

$2.77
+0.01 (+0.36 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.70
Now: $2.77
$2.88
50-Day Range
$1.97
MA: $2.43
$2.91
52-Week Range
$0.45
Now: $2.77
$3.25
Volume181,857 shs
Average Volume538,646 shs
Market Capitalization$306.42 million
P/E RatioN/A
Dividend YieldN/A
Beta1.91
NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, as well as whole transcriptome sequencing; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; Liquid GPS, a blood-based molecular test; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Read More
NantHealth logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.11 out of 5 stars


Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone310-883-1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$95.96 million
Book Value($0.52) per share

Profitability

Net Income$-62,760,000.00

Miscellaneous

Employees543
Market Cap$306.42 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

NantHealth (NASDAQ:NH) Frequently Asked Questions

How has NantHealth's stock been impacted by COVID-19 (Coronavirus)?

NantHealth's stock was trading at $1.81 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NH shares have increased by 53.0% and is now trading at $2.77. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NantHealth?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NantHealth.

When is NantHealth's next earnings date?

NantHealth is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for NantHealth.

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) announced its earnings results on Thursday, May, 7th. The company reported ($0.06) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.06). The business had revenue of $18.18 million for the quarter, compared to analysts' expectations of $19.30 million. View NantHealth's earnings history.

What price target have analysts set for NH?

1 equities research analysts have issued 1 year price targets for NantHealth's shares. Their forecasts range from $1.00 to $1.00. On average, they expect NantHealth's share price to reach $1.00 in the next twelve months. This suggests that the stock has a possible downside of 63.9%. View analysts' price targets for NantHealth.

Has NantHealth been receiving favorable news coverage?

Media stories about NH stock have been trending somewhat positive on Friday, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NantHealth earned a media sentiment score of 0.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutNantHealth.

Are investors shorting NantHealth?

NantHealth saw a increase in short interest in April. As of April 30th, there was short interest totaling 278,200 shares, an increase of 51.3% from the April 15th total of 183,900 shares. Based on an average trading volume of 677,800 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.7% of the shares of the stock are sold short. View NantHealth's Current Options Chain.

Who are some of NantHealth's key competitors?

What other stocks do shareholders of NantHealth own?

Who are NantHealth's key executives?

NantHealth's management team includes the following people:
  • Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)
  • Mr. Ronald Allen Louks, COO & Director (Age 54)
  • Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)
  • Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
  • Mr. Charles Hunt, VP of Marketing, Communications & User Experience

When did NantHealth IPO?

(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include DG Capital Management LLC (12.49%), Miracle Mile Advisors LLC (0.36%), Geode Capital Management LLC (0.25%), JPMorgan Chase & Co. (0.11%) and Jane Street Group LLC (0.03%). View institutional ownership trends for NantHealth.

Which major investors are selling NantHealth stock?

NH stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC. View insider buying and selling activity for NantHealth.

Which major investors are buying NantHealth stock?

NH stock was purchased by a variety of institutional investors in the last quarter, including DG Capital Management LLC, Miracle Mile Advisors LLC, JPMorgan Chase & Co., and Jane Street Group LLC. View insider buying and selling activity for NantHealth.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $2.77.

How big of a company is NantHealth?

NantHealth has a market capitalization of $306.42 million and generates $95.96 million in revenue each year. The company earns $-62,760,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. NantHealth employs 543 workers across the globe.

What is NantHealth's official website?

The official website for NantHealth is www.nanthealth.com.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.